158 filings
Page 4 of 8
8-K
LTRN
Lantern Pharma Inc
22 Nov 21
Lantern Pharma Announces Share Repurchase Program
9:00am
4
BIOS Capital Management, LP
8 Nov 21
Lantern Pharma / Aaron G.L. Fletcher ownership change
5:23pm
4
Prendergast Franklyn G
8 Nov 21
Lantern Pharma / FRANKLYN G PRENDERGAST ownership change
4:05pm
4
Vijay Chandru
8 Nov 21
Lantern Pharma / Vijay Chandru ownership change
4:05pm
4
David S. Silberstein
8 Nov 21
Lantern Pharma / David S. Silberstein ownership change
4:05pm
4
LTRN
Lantern Pharma Inc
8 Nov 21
Lantern Pharma / D JEFFREY KEYSER ownership change
4:05pm
4
Kishor G. Bhatia
2 Nov 21
Lantern Pharma / Kishor G. Bhatia ownership change
4:06pm
4
David R. Margrave
2 Nov 21
Lantern Pharma / David R. Margrave ownership change
4:05pm
10-Q
2021 Q3
LTRN
Lantern Pharma Inc
Quarterly report
1 Nov 21
4:06pm
8-K
LTRN
Lantern Pharma Inc
1 Nov 21
Lantern Pharma Reports Third Quarter 2021 Financial Results and Operating Highlights
4:05pm
10-Q
2021 Q2
LTRN
Lantern Pharma Inc
Quarterly report
29 Jul 21
4:02pm
8-K
LTRN
Lantern Pharma Inc
29 Jul 21
Lantern Pharma Reports Second Quarter 2021 Financial Results and Operational Highlights
4:01pm
EFFECT
LTRN
Lantern Pharma Inc
13 Jul 21
Notice of effectiveness
12:15am
CORRESP
LTRN
Lantern Pharma Inc
8 Jul 21
Correspondence with SEC
12:00am
UPLOAD
LTRN
Lantern Pharma Inc
7 Jul 21
Letter from SEC
12:00am
S-3
LTRN
Lantern Pharma Inc
2 Jul 21
Shelf registration
4:15pm
8-K
LTRN
Lantern Pharma Inc
25 May 21
Submission of Matters to a Vote of Security Holders
11:12am
8-K
LTRN
Lantern Pharma Inc
3 May 21
Lantern Pharma Reports First Quarter 2021 Financial Results and Operational Highlights
4:12pm
10-Q
2021 Q1
LTRN
Lantern Pharma Inc
Quarterly report
3 May 21
4:01pm
DEFA14A
LTRN
Lantern Pharma Inc
9 Apr 21
Additional proxy soliciting materials
11:32am